Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAPOR-2 kidney transplant anesthesia trial
NL-OMON50373Recruiting
- Sponsor
- Anesthesiologie - Onderzoeksbureau (UMCG)
- Start
- Apr 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane, propofol and remifentanil in kidney failure and end-stage kidney disease (ESKD) (2 arms), sponsored by Anesthesiologie - Onderzoeksbureau (UMCG). Primary endpoint: Delayed graft function. Started Apr 2017; status: recruiting.
02
Drugs
sevofluranepropofolremifentanil
03
Conditions
kidney failureend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on NL-OMON50373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50373.